TherapeuticsMD, Inc. (TXMD) Net Income by Year
TherapeuticsMD, Inc. reported a net loss of $569K in fiscal year 2025. This represents an increase of 73.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $217K net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters TherapeuticsMD, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TXMD Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K/A | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$217K | -$569K+73.9% | -$2.2M+78.8% | -$10.3M-109.2% | $112.0M+165.0% | -$172.4M+6.1% | -$183.5M-4.2% | -$176.1M-32.8% | -$132.6M-72.4% | -$76.9M+14.4% | -$89.9M-5.6% | -$85.1M-56.9% | -$54.2M-90.8% | -$28.4M | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
TXMD Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More TherapeuticsMD, Inc. financials
Frequently Asked Questions
What was TherapeuticsMD, Inc.'s net income in fiscal year 2025?
TherapeuticsMD, Inc. reported a net loss of $569K in fiscal year 2025.
How fast is TherapeuticsMD, Inc.'s net income growing?
TherapeuticsMD, Inc. (TXMD) net income rose by 73.9% year over year, from -$2.2M to -$569K in fiscal year 2025.
What is TherapeuticsMD, Inc.'s net income over the last twelve months?
TherapeuticsMD, Inc. (TXMD) reported a $217K net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was TherapeuticsMD, Inc.'s net income in the most recent quarter?
TherapeuticsMD, Inc. (TXMD) reported $155K in net income in Q2 2026. This represents a decrease of 71.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what TherapeuticsMD, Inc. (TXMD) reported on that line in every period on record.